Citation Impact
Citing Papers
Rosiglitazone (BRL49653), a PPARγ-selective agonist, causes peroxisome proliferator-like liver effects in obese mice
1999
Role of cytokines in non-genotoxic hepatocarcinogenesis: cause or effect?
2001
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Photodynamic Therapy
1998 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Role of ROS and RNS Sources in Physiological and Pathological Conditions
2016 Standout
PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance
2003
ALA and its clinical impact, from bench to bedside
2007
Peroxisome-proliferator-activated receptors and cancers: complex stories
2004
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
2007 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Mechanism of Action of the Nongenotoxic Peroxisome Proliferators: Role of the Peroxisome Proliferator-Activated Receptor
1998
Steatohepatitis, Spontaneous Peroxisome Proliferation and Liver Tumors in Mice Lacking Peroxisomal Fatty Acyl-CoA Oxidase
1998
The peroxisome proliferator (PP) response element upstream of the human acyl CoA oxidase gene is inactive among a sample human population: significance for species differences in response to PPs
1999
Characterization of risk for general population exposure to perfluorooctanoate
2004
PPAR: a mediator of peroxisome proliferator action
1995
Photodynamic therapy for cancer
2003 Standout
Lack of oestrogenic effects of food preservatives (parabens) in uterotrophic assays
2000
The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells
1996
Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model
2003 Standout
Effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes
2003
Peroxisome Proliferator‐activated Receptors: Stuctures and Function
1996
A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations
2008 StandoutNobel
-Catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol
2001 Standout
Natural products in crop protection
2009 Standout
Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences
1999
Cytokines in non-genotoxic hepatocarcinogenesis
1999
Dose-Dependent Alterations in Androgen-Regulated Male Reproductive Development in Rats Exposed to Di(n-butyl) Phthalate during Late Gestation
2000 Standout
Anti-infective potential of natural products: How to develop a stronger in vitro ‘proof-of-concept’
2006 Standout
Cellular damage to human hepatocytes through repeated application of 5-aminolevulinic acid
2003
Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha)
1998
Safety assessment of esters of p-hydroxybenzoic acid (parabens)
2005 Standout
The Development of New Concepts for Assessing Reproductive Toxicity Applicable to Large Scale Toxicological Programmes
2007
Species differences in sequence and activity of the peroxisome proliferator response element (PPRE) within the acyl CoA oxidase gene promoter
1999
The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions
2017
Inflammation and cancer: back to Virchow?
2001 Standout
Cellular Fatty Acid Metabolism and Cancer
2013 Standout
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Teratogenic phthalate esters and metabolites activate the nuclear receptors PPARs and induce differentiation of F9 cells
2003
Photodynamic therapy of cancer: An update
2011 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
The hormone resistin links obesity to diabetes
2001 StandoutNature
The Top 10 fungal pathogens in molecular plant pathology
2012 Standout
Ecotoxicology of human pharmaceuticals
2005 Standout
Toxicity of Ammonium Perfluorooctanoate in Male Cynomolgus Monkeys after Oral Dosing for 6 Months
2002
Environmentally induced oxidative stress in aquatic animals
2010 Standout
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
2001 Standout
Nonalcoholic fatty liver disease
2005 Standout
Toxicology for the twenty-first century
2009 StandoutNature
In honor of the Teratology Society's 50th anniversary: The role of Teratology Society members in the development and evolution of in vivo developmental toxicity test guidelines
2010
Peroxisome Proliferator-Activated Receptor-alpha and the Pleiotropic Responses to Peroxisome Proliferators
1998
Neurobehavioural effects of developmental toxicity
2014 Standout
trans-Activation of PPARα and PPARγ by Structurally Diverse Environmental Chemicals
1999
Activation of PPAR and PPAR by Environmental Phthalate Monoesters
2003
Induction of Cyclooxygenase-2 Expression by Peroxisome Proliferators and Non-tetradecanoylphorbol 12,13-Myristate-type Tumor Promoters in Immortalized Mouse Liver Cells
1997
Enantioselectivity in the induction of peroxisome proliferation by 2‐ethylhexanoic acid
1992
Expression of the Immediate–Early Genes, c-fos,c-jun,and c-myc:A Comparison in Rats of Nongenotoxic Hepatocarcinogens with Noncarcinogenic Liver Mitogens
1997
Fifteen Years after “Wingspread”—Environmental Endocrine Disrupters and Human and Wildlife Health: Where We are Today and Where We Need to Go
2008
Fungicide-Driven Evolution and Molecular Basis of Multidrug Resistance in Field Populations of the Grey Mould Fungus Botrytis cinerea
2009
HIF-1beta determines ABCA1 expression under hypoxia in human macrophages
2009 StandoutNobel
Photodynamic Therapy (PDT) and Photodiagnosis (PD) Using Endogenous Photosensitization Induced by 5-Aminolevulinic Acid (ALA): Mechanisms and Clinical Results
1996
The Toxicology of Perfluorooctanoate
2004
The plasticizer market: an assessment of traditional plasticizers and research trends to meet new challenges
2004 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Testing of antifungal natural products: methodologies, comparability of results and assay choice
2000
Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol
2003 StandoutNobel
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
Water Analysis: Emerging Contaminants and Current Issues
2014 Standout
The Mechanisms of Action of PPARs
2002 Standout
Microbial Fungicides in the Control of Plant Diseases
2007
A Retrospective Performance Assessment of the Developmental Neurotoxicity Study in Support of OECD Test Guideline 426
2008
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
Use of Plant Growth-Promoting Bacteria for Biocontrol of Plant Diseases: Principles, Mechanisms of Action, and Future Prospects
2005 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
1997 Standout
New photosensitizers for photodynamic therapy
2016 Standout
Redox Regulation of Homeostasis and Proteostasis in Peroxisomes
2017
Applications and societal benefits of plastics
2009 Standout
Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?
1998
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Decreased susceptibility to copper‐induced oxidation of rat‐lipoproteins after fibrate treatment: influence of fatty acid composition
1996
Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers
2007 Standout
Plant growth-promoting bacteria in the rhizo- and endosphere of plants: Their role, colonization, mechanisms involved and prospects for utilization
2009 Standout
Isolation, identification, and antifungal activity of a macrolide antibiotic, oligomycin A, produced by Streptomyces libani
1999
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Works of A.M. Brady being referenced
The oral administration of Polysorbate 80 to the immature female rat does not increase uterine weight
1997
Inhibition of ferrochelatase and accumulation of porphyrins in mouse hepatocyte cultures exposed to porphyrinogenic chemicals
1992
A Tiered Approach to Life Stages Testing for Agricultural Chemical Safety Assessment
2006
Identification of the proximate peroxisome proliferator(S) derived from DI (2-ethylhexyl) adipate and species differences in response
1992
Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis
1994
RATIONALE AND PERSPECTIVES ON THE DEVELOPMENT OF FUNGICIDES
1997